Fudan University: all 1,308 studies
Page 1 of 14. Open to participants first (637), then studies with results posted, then the rest; newest registration first within each.
- First-line Treatment With Dual Immunotherapy Combined With Anti-angiogenesis for Unresectable Advanced Malignant Peritoneal MesotheliomaNot yet recruitingNCT07893340Phase 2
- Thymalfasin Combined With Chemotherapy and Immunotherapy in TNBC Neoadjuvant TreatmentNot yet recruitingNCT07884201Phase 2
- Becotatug Vedotin Plus Pucotenlimab for Metastatic Colorectal CancerRecruitingNCT07884188Phase 2
- A Phase II Study of Ipilimumab N01 Plus Sintilimab for MSI-H or dMMR Gastric and Gastroesophageal Junction CancerNot yet recruitingNCT07878221Phase 2
- Chemotherapy Combined With or Without Short-Course Radiotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for High-Risk Locally Advanced Colon Cancer With pMMR/MSSNot yet recruitingNCT07877597Phase 3
- Retlirafusp Alfa Combined With Zeprumetostat, Apatinib, and Chemotherapy as First-Line Treatment for Metastatic GC/GEJCNot yet recruitingNCT07874425Phase 2
- Artificial Intelligence-assisted Primary Care for Influenza Vaccination Among Chronic Patients in China (AIPC-Flu)Not yet recruitingNCT07873255Not applicable
- Family Physician Nudges for Influenza Vaccination Among Older AdultsNot yet recruitingNCT07864597Not applicable
- Hemodynamic Characteristics of Peripheral Arterial Disease Using Computational Fluid DynamicsNot yet recruitingNCT07860138
- Vaccine Knowledge, Attitudes and Practices Among Men Who Have Sex With Men: a Global Cross-sectional StudyNot yet recruitingNCT07856563
- SHR-A1811 Versus Trastuzumab Plus Pertuzumab in ctDNA-Positive HER2-Positive Early Breast Cancer After Pathologic Complete ResponseNot yet recruitingNCT07856303Phase 2
- Artificial Intelligence-assisted Primary Care for RSV Prevention (AIPC-RSV) in ChinaNot yet recruitingNCT07856290Not applicable
- Cryoablation Combined With Anlotinib Plus TQB2868 in Patients With Advanced Intrahepatic CholangiocarcinomaNot yet recruitingNCT07846267Phase 2
- Exploring the Impact of Diurnal Variation on Coagulation Function in Patients Undering Tumor SurgeryEnrolling by invitationNCT07841613
- ctDNA-Guided Immunotherapy for dMMR/MSI-H Colon CancerRecruitingNCT07841236Phase 2
- SCRT Combined With CAPOX and PD-1/CTLA4 Antibody for Early-stage Low Rectal CancerNot yet recruitingNCT07837362Phase 2
- Hypofractionated vs. Conventionally Fractionated Postmastectomy Radiotherapy After Implant-Based ReconstructionRecruitingNCT07835139Not applicable
- 1-Week Versus 3-Week PBIRecruitingNCT07832279Not applicable
- Cryoablation Combined With QL1706 (Iparomlimab/Tuvonralimab) Plus Lenvatinib in Patients With Advanced Biliary Tract Cancer.Not yet recruitingNCT07829874Phase 2
- Response-Adapted Omission of Nodal Boost In N3 Breast Cancer After Neoadjuvant Systemic TherapyRecruitingNCT07829848Not applicable
- Chemotherapy Exemption in Elderly Women With Node-Positive ER+/HER2- Breast CancerNot yet recruitingNCT07826052Phase 2
- Protein-Matched ADC or PDC Umbrella Trial in Advanced Pancreatic and Breast CancerNot yet recruitingNCT07825753Phase 2
- Consolidative Stereotactic Radiotherapy for Oligo-Residual Advanced EGFR-Mutant NSCLC After First-Line Third-Generation EGFR-TKI Plus ChemotherapyNot yet recruitingNCT07822984Phase 2
- MANTIS-RCC: Toripalimab-Axitinib Induction in TLS-Positive Advanced Non-Clear Cell and Renal Medullary CarcinomasNot yet recruitingNCT07816770Phase 2
- Clinical Value of CT Perfusion in Peripheral Artery DiseaseNot yet recruitingNCT07816757
- FAPI-Guided Radiotherapy With Cadonilimab and Standard Chemotherapy for Colorectal Peritoneal Metastasis: A Phase III Randomized Controlled Trial (TORHC-PM02)RecruitingNCT07815834Phase 3
- Total Neoadjuvant mFOLFOX6 Plus Suvemcitug and Enlonstobart With Selective Omission of Pelvic Radiotherapy for High-Risk Mid-Rectal Locally Advanced Rectal CancerNot yet recruitingNCT07810114Phase 2
- Olive Oil Before Lung Cancer Surgery to Prevent ChylothoraxRecruitingNCT07807696Not applicable
- AI-Assisted Patient Support in mHSPCNot yet recruitingNCT07804030Not applicable
- Station 4L Lymph Node Dissection Versus No Dissection in Clinical Stage I Solid Nodule-Type Invasive NSCLCRecruitingNCT07801430Not applicable
- Immediate Autologous Tissue Breast Reconstruction and Radiotherapy Strategy After Breast Cancer SurgeryEnrolling by invitationNCT07798466
- Correlation Between Artificial Intelligence-Based Fecal Coverage Area-Quantified Bowel Preparation Quality Score (FQ-BBPS) and Adenoma Detection RateNot yet recruitingNCT07795788
- APEX-STROKE EAGLE Domain (EAGLE)Not yet recruitingNCT07790354Phase 3
- Induction Chemotherapy Response-Guided Reduced-Dose Radiotherapy for Nasopharyngeal CarcinomaNot yet recruitingNCT07789158Phase 2
- APEX-STROKE Adaptive Platform Trial for StrokeNot yet recruitingNCT07784569Phase 3
- Real-World Study of Niraparib in First-Line Maintenance Therapy for Advanced Epithelial Ovarian CancerRecruitingNCT07783022
- Response-adapted Postoperative Radiotherapy In Locally Advanced Head and Neck CancerNot yet recruitingNCT07780877Phase 2
- The Study Of Andamertinib Plus Anlotinib In Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerNot yet recruitingNCT07780578Phase 2
- Selective Coverage Versus Comprehensive Coverage Radiotherapy in Poorly Differentiated and Anaplastic Thyroid CancerRecruitingNCT07777536Phase 2
- TACTIC-RCC: Toripalimab Plus Axitinib Induction With Selective Deferred Cytoreductive Nephrectomy in TLS-Positive Advanced Clear Cell Renal Cell CarcinomaNot yet recruitingNCT07776717Phase 2
- Induction PD-1 Inhibitor and Chemotherapy Followed by Chemoradiotherapy in Unresectable or Inoperable HPV-negative LA-HNSCCNot yet recruitingNCT07776340Phase 2
- Application of CT-Linac-Based "All-in-One" One-Stop Radiotherapy in Breast CancerRecruitingNCT07776301Not applicable
- Romiplostim N01 for Injection for Secondary Prophylaxis of CIT in Breast CancerNot yet recruitingNCT07771881Phase 2
- GELAD-Based Response-Adapted Treatment for Early-Stage Extranodal NK/T-Cell LymphomaNot yet recruitingNCT07768943Phase 2
- Dynamic Risk-adapted EBV-DNA and MRI-guided De-concurrent Chemotherapy in Nasopharyngeal CarcinomaRecruitingNCT07762976Phase 2
- Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Following Breast-Conserving SurgeryRecruitingNCT07762924Phase 2
- Omission of Adjuvant Radiotherapy in Low- and Intermediate-Risk Ductal Carcinoma In Situ After Breast-Conserving SurgeryRecruitingNCT07762885Phase 3
- An Open-Label, Randomized Phase III Study of Trastuzumab Rezetecan With or Without Everolimus in First to Third Line LAR Subtype TNBCNot yet recruitingNCT07760844Phase 3
- The Necessity of Surgery in Patients With mGC Achieving Radiological Response After Conversion TherapyRecruitingNCT07757165Phase 2
- Stereotactic Body Radiotherapy for the Treatment of Distant Metastases in Thyroid Cancer: A Phase II Prospective Clinical StudyEnrolling by invitationNCT07755423
- APEX-STROKE CALM-ICH DomainNot yet recruitingNCT07752719Phase 3
- AI-Guided TURBT for Bladder CancerNot yet recruitingNCT07727343Not applicable
- Fulvestaciclib Combined With Anti-HER2 and Endocrine Therapy for HR+/HER2+ Advanced Breast CancerNot yet recruitingNCT07716046Phase 2
- Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild Cognitive ImpairmentRecruitingNCT07711171Phase 4
- Real-World Study of Young Patients With Solid Tumors in ChinaRecruitingNCT07708935
- Granzyme B-PET: Predicting Immunotherapy Efficacy in TNBCRecruitingNCT07705438
- Dietary Pattern Intervention for Neurodevelopment in Preterm InfantsNot yet recruitingNCT07702734Not applicable
- PD-1 Inhibitors Combined With Local Therapy at Different Timings in Oligometastatic ESCCRecruitingNCT07697859
- A Multicenter, Single Arm Study to Evaluate the Preliminary Efficacy and Safety Profile of Inavolisib in Previously Treated Pancreatic Ductal Adenocarcinoma PatientsNot yet recruitingNCT07694973Phase 2
- Savolitinib Plus Cetuximab and FOLFOX Chemotherapy for RAS/BRAF Wild-type Metastatic Colorectal CancerNot yet recruitingNCT07683403Phase 1/2
- An Open-Label, Randomized Phase III Study of Trastuzumab Rezetecan With or Without Bevacizumab in First to Third Line BLIS Subtype TNBCNot yet recruitingNCT07669610Phase 3
- A Phase II Clinical Study of the Efficacy and Safety of Culmerciclib Rechallenge in HR-positive, HER2-negative Breast Cancer Patients With Resistance to First-line Endocrine Therapy.RecruitingNCT07666555Phase 2
- Iparomlimab and Tovorilimab (QL1706) Combined With Bevacizumab and Chemotherapy as Neoadjuvant Therapy for Advanced Ovarian CancerNot yet recruitingNCT07663513Phase 2
- Sacituzumab Tirumotecan vs MMAE-ADCs in Advanced Urothelial Carcinoma (FUSCC-SPARE-UC-01)Not yet recruitingNCT07662863Phase 2
- Epidemiology and Prognostic Analysis of Chinese Cancer Patients With Cancer-related FatigueRecruitingNCT07656324
- A Phase II Observational Clinical Study on the Relationship Between Cerebrospinal Fluid Drug Concentration and Efficacy of Trastuzumab Deruxtecan in Central Nervous System Metastatic Breast CancerRecruitingNCT07653893
- A Clinical Study on Prophylactic RespOnse To hEtrombopag for Secondary Prevention in Anti-Cancer Therapy-induced ThrombocytopeniaeNot yet recruitingNCT07647029Phase 2
- Trastuzumab Deruxtecan Plus ivonescImab for Hormone Receptor-positive HER2 Negative Advanced Breast Cancer StudyRecruitingNCT07647016Phase 2
- The Effects of Different Anesthetics on the Brain's Neural NetworksNot yet recruitingNCT07644663Phase 4
- Study of Radiotherapy Combined With Cisplatin/Carboplatin, Adebrelimab and Bevacizumab in the Treatment of TNBC-BM.RecruitingNCT07638852Phase 2
- The Efficacy of Compression/Ice Gloves/Socks in Patients With UTD1-induced Neuropathy.RecruitingNCT07638774Not applicable
- Sac-TMT Sequential Capecitabine Versus Capecitabine in Early-Stage High-Risk Triple-Negative Breast Cancer Without BRCA MutationsNot yet recruitingNCT07628504Phase 3
- Association Between Screening Behaviors and Lung Cancer SpectrumRecruitingNCT07626177
- Sac-TMT Combined With Bevacizumab in TNBC With Brain MetastasesRecruitingNCT07623577Phase 2
- SHR-1701 for Induction and Consolidation Therapy in Unresectable Stage III Non-Small Cell Lung CancerNot yet recruitingNCT07619911Phase 2
- Probiotics Supplementation for Neurodevelopment in Preterm InfantsNot yet recruitingNCT07617181Not applicable
- Pyrotinib and Trastuzumab Combined With Dalpiciclib Versus Combined With Docetaxel in Advanced HER2-Positive Breast CancerRecruitingNCT07615751Phase 3
- AI-empowered Nudge to Improve Colonoscopy Uptake (AINC)Not yet recruitingNCT07612436Not applicable
- Impact of Formulation Change on Ovarian Suppression in Young Breast Cancer Patients.Not yet recruitingNCT07610733Phase 2
- A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant ChemotherapyRecruitingNCT07604909Phase 2
- Perioperative Safety and Long-Term Outcomes of Mesh Repair in Nonagenarians Undergoing Elective Inguinal Hernia RepairNot yet recruitingNCT07602647
- HER2-PET: Predicting T-DXd Efficacy and HER2 HeterogeneityRecruitingNCT07586215
- Anemia on Sublingual Microcirculation in GDFTEnrolling by invitationNCT07583927
- Study of Paclitaxel Polymeric Micelles Combined With HP and Adebelimab Versus Taxane Combined With HP as First-Line Treatment for Advanced HER2-Positive Breast CancerNot yet recruitingNCT07581795Phase 2
- Molecular Subtyping of Breast Cancer-derived Small Extracellular Vesicles (sEVs) to Predict Therapeutic EfficacyRecruitingNCT07574749
- A Prospective Study of Tumor-specific Tpex in Negative Lymph Nodes for Predicting Pathological Complete Response to Neoadjuvant PD 1 Therapy in Esophageal CancerNot yet recruitingNCT07573397
- Randomized Study of Plasma ctDNA Methylation to Guide Adjuvant Chemotherapy Decisions in High-Risk T3N0 Colorectal CancerRecruitingNCT07562711Phase 2
- Randomized Controlled Study of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy in Stage I/Low-Risk Stage II Colorectal CancerRecruitingNCT07562659Phase 2
- Randomized Trial of Plasma ctDNA Methylation-Guided Adjuvant Therapy in T4N0 and Low-Risk Stage III Colorectal CancerRecruitingNCT07562503Phase 2
- A Randomized Controlled Trial of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy Decision-Making in High-Risk Stage III (T4N+ or T1-3N2) Colorectal CancerRecruitingNCT07562490Phase 2
- Low Rectal Cancer Treated With Total Neoadjuvant Therapy Plus Concurrent Tislelizumab ImmunotherapyRecruitingNCT07561060Phase 1/2
- Multicentric Database for KRAS Mutant Pancreatic CancerRecruitingNCT07557849
- Opportunistic Breast Cancer Screening Using Non-Contrast Chest CTRecruitingNCT07557654
- Chemoradiotherapy and Anti-PD-1 Antibody in Anal Squamous Cell Cancer：ChaseRecruitingNCT07555678Phase 2
- Comparison of Perioperative Immunotherapy, Adjuvant Immunotherapy or Neoadjuvant Immunotherapy for Resectable Stage II-IIIA NSCLCRecruitingNCT07554846Phase 3
- SCRT Based iTNT vs. LCRT Based TNT for MSS Locally Advanced Rectal CancerNot yet recruitingNCT07551479Phase 3
- Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Breast CancerRecruitingNCT07551050
- Pinoxin for the Prevention of Radiation-Induced Skin InjuryRecruitingNCT07545720Phase 2
- AK104 Plus Radiotherapy Combined With Standard Therapy Versus Standard Therapy as First-Line Treatment for pMMR/MSS CRLM (APSOC)RecruitingNCT07544784Phase 2
- Digital Mind-Body Therapy for Neoadjuvant Breast CancerRecruitingNCT07541664Not applicable